Startups
Our missions is to personalize drug dosing for chronically administered drugs.
Dosis' first product, Strategic Anemia Advisor, is a web-based reference tool that personalizes dosing of ESAs, a class of drugs used to treat chronic anemia. SAA is proven to help reduce outlier hemoglobins by up to 65%, while simultaneously reducing ESA use by up to 50%. We charge absolutely nothing upfront, and charge only a share of the savings.
Dosis' first product, Strategic Anemia Advisor, is a web-based reference tool that personalizes dosing of ESAs, a class of drugs used to treat chronic anemia. SAA is proven to help reduce outlier hemoglobins by up to 65%, while simultaneously reducing ESA use by up to 50%. We charge absolutely nothing upfront, and charge only a share of the savings.
Overview
Location
United States, California, San Francisco
Employees
1-10
Phone
+1 650-383-0186
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 23, 2021 | Dosis Expands Dosing Platform to Personalize Anemia Management | What You Should Know: – Dosis, the AI-powered precision dosing platform on a mission to transform healthcare, has announced the release of its Strategic Iron Advisor (SIA) tool, the first precision dosing tool on the market for intravenous ... |
| Aug 20, 2021 | Dosis Expands Kidney Care Platform With Iron Advisor Tool To Personalize Anemia Management | First Application of Its Kind Broadens Capabilities of Dosis’s Personalized Dosing Platform Dosis, a market leader in artificial intelligence-powered precision dosing, announced the expansion of its kidney care platform with the release of ... |
Reviews 0
FAQ about DOSIS
What has the press written about DOSIS?
Parsers VC has collected 3 articles mentioning DOSIS, among them “Dosis Expands Dosing Platform to Personalize Anemia Management” (Aug 23, 2021) and “Dosis Expands Kidney Care Platform With Iron Advisor Tool To Personalize Anemia Management” (Aug 20, 2021).
Is DOSIS still active?
Yes, DOSIS is active; its latest activity on Parsers VC dates from Oct 17, 2022.